Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joan Gibble

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Transfusion|December 11, 2012
Analyzing actual risk in malaria-deferred donors through selective serologic testingMegan L Nguyen, Tami Goff, Joan Gibble, et al.
Transfusion|May 1, 2007
Radiofrequency identification technology can standardize and document blood collections and transfusionsS Gerald Sandler, Al Langeberg, Leo DeBandi, et al.
Transfusion|October 26, 2007
Pasteurella multocida bacteremia in asymptomatic plateletpheresis donors: a tale of two catsBarbara J Bryant, Cathy Conry-Cantilena, Alice Ahlgren, et al.
Transfusion|February 7, 2012
The clinical relevance of persistent recombinant immunoblot assay-indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counselingAddisalem T Makuria, Sukanya Raghuraman, Peter D Burbelo, et al.
The Journal of Infectious Diseases|June 29, 2012
A 25-year study of the clinical and histologic outcomes of hepatitis C virus infection and its modes of transmission in a cohort of initially asymptomatic blood donorsRobert D Allison, Cathy Conry-Cantilena, Deloris Koziol, et al.
Transfusion|November 9, 2011
Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALISuzanne A Arinsburg, Donna L Skerrett, Julie K Karp, et al.
Blood|August 30, 2008
Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infectionMelissa T Bartman, Zhanna Kaidarova, Dale Hirschkorn, et al.
Transfusion|July 18, 2008
The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006Anne F Eder, Beth A Dy, Jean M Kennedy, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Transfusion|December 11, 2012
Analyzing actual risk in malaria-deferred donors through selective serologic testingMegan L Nguyen, Tami Goff, Joan Gibble, et al.
Transfusion|May 1, 2007
Radiofrequency identification technology can standardize and document blood collections and transfusionsS Gerald Sandler, Al Langeberg, Leo DeBandi, et al.
Transfusion|October 26, 2007
Pasteurella multocida bacteremia in asymptomatic plateletpheresis donors: a tale of two catsBarbara J Bryant, Cathy Conry-Cantilena, Alice Ahlgren, et al.
Transfusion|February 7, 2012
The clinical relevance of persistent recombinant immunoblot assay-indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counselingAddisalem T Makuria, Sukanya Raghuraman, Peter D Burbelo, et al.
The Journal of Infectious Diseases|June 29, 2012
A 25-year study of the clinical and histologic outcomes of hepatitis C virus infection and its modes of transmission in a cohort of initially asymptomatic blood donorsRobert D Allison, Cathy Conry-Cantilena, Deloris Koziol, et al.
Transfusion|November 9, 2011
Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALISuzanne A Arinsburg, Donna L Skerrett, Julie K Karp, et al.
Blood|August 30, 2008
Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infectionMelissa T Bartman, Zhanna Kaidarova, Dale Hirschkorn, et al.
Transfusion|July 18, 2008
The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006Anne F Eder, Beth A Dy, Jean M Kennedy, et al.
Pageof 1